MDT Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	6.22M
Vidutinė apimtis	6.30M
Rinkos kapitalizacija	107.45B
EPS	$0 ( 2024-04-07 )
Kita pelno data	( $1.260 ) 2024-05-23
Last Dividend	$0.690 ( 2023-09-21 )
Next Dividend	$0 ( N/A )
P/E	25.69
ATR14	$0.0450 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-29	Powell Kendall J	Buy	2 165	Ordinary Shares
2024-04-29	Oleary Denise M	Buy	2 165	Ordinary Shares
2024-04-29	Nabel Elizabeth G	Buy	2 165	Ordinary Shares
2024-04-29	Lofton Kevin E	Buy	2 165	Ordinary Shares
2024-04-29	Lewis Gregory P	Buy	1 821	Ordinary Shares

INSIDER POWER
66.09
Last 100 transactions
Buy: 1 293 600 \| Sell: 250 831

Tūris Koreliacija

Ilgas: -0.15 (neutral)

Trumpas: 0.73 (moderate)

Signal:(51.113) Neutral

Medtronic PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Medtronic PLC Koreliacija - Valiuta/Žaliavos

0.43
( neutral )

0.24
( neutral )

0.00
( neutral )

0.24
( neutral )

0.63
( weak )

-0.01
( neutral )

Medtronic PLC Finansinės ataskaitos

Annual	2023
Pajamos:	$31.23B
Bruto pelnas:	$20.51B (65.67 %)
EPS:	$2.85

FY	2023
Pajamos:	$31.23B
Bruto pelnas:	$20.51B (65.67 %)
EPS:	$2.85

FY	2023
Pajamos:	$31.23B
Bruto pelnas:	$20.51B (65.67 %)
EPS:	$2.83

FY	2022
Pajamos:	$31.69B
Bruto pelnas:	$21.54B (67.98 %)
EPS:	$3.75

Financial Reports:

No articles found.

Medtronic PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.680 (N/A)	$0.680 (N/A)	$0.680 (N/A)	$0.690 (N/A)	$0.690 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Medtronic PLC Dividend Information - Dividend King

Dividend Sustainability Score: 9.19 - good (91.95%) | Divividend Growth Potential Score: 3.66 - Decrease likely (26.76%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00219	1982-01-04
Last Dividend	$0.690	2023-09-21
Next Dividend	$0	N/A
Payout Date	2023-10-13
Next Payout Date	N/A
# dividends	167	--
Total Paid Out	$27.99	--
Avg. Dividend % Per Year	1.62%	--
Score	5.08	--
Div. Sustainability Score	9.19
Div.Growth Potential Score	3.66
Div. Directional Score	6.43	--

Next Divdend (Est)
(2024-07-31)

$0.698 Estimate 21.86 %

Dividend Stability

0.58 Average

Dividend Score

5.08

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1982	$0.00938	1.55%
1983	$0.0106	1.26%
1984	$0.0116	1.72%
1985	$0.0122	2.89%
1986	$0.0131	1.94%
1987	$0.0150	1.24%
1988	$0.0134	0.90%
1989	$0.0203	1.67%
1990	$0.0238	1.16%
1991	$0.0286	1.09%
1992	$0.0325	0.56%
1993	$0.0387	0.65%
1994	$0.0595	1.15%
1995	$0.0454	0.68%
1996	$0.0802	0.62%
1997	$0.103	0.61%
1998	$0.120	0.48%
1999	$0.145	0.40%
2000	$0.181	0.53%
2001	$0.215	0.36%
2002	$0.299	0.60%
2003	$0.280	0.60%
2004	$0.243	0.50%
2005	$0.362	0.73%
2006	$0.413	0.71%
2007	$0.470	0.89%
2008	$0.813	1.64%
2009	$0.598	1.83%
2010	$0.860	1.96%
2011	$0.936	2.50%
2012	$1.266	3.27%
2013	$1.100	2.63%
2014	$1.195	2.09%
2015	$1.445	2.01%
2016	$1.670	2.20%
2017	$1.810	2.56%
2018	$1.460	1.78%
2019	$2.12	2.41%
2020	$2.28	1.99%
2021	$2.47	2.13%
2022	$2.67	2.52%
2023	$2.06	2.63%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
ZTR	Dividend Royal	2024-02-09	Monthly	37	8.35%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.130	1.500	7.40	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0462	1.200	8.46	10.00	[0 - 0.3]
returnOnEquityTTM	0.0816	1.500	-0.204	-0.307	[0.1 - 1]
payoutRatioTTM	0.871	-1.000	1.293	-1.293	[0 - 1]
currentRatioTTM	2.30	0.800	3.51	2.80	[1 - 3]
quickRatioTTM	1.459	0.800	6.12	4.90	[0.8 - 2.5]
cashRatioTTM	0.166	1.500	-0.190	-0.286	[0.2 - 2]
debtRatioTTM	0.277	-1.500	5.39	-8.08	[0 - 0.6]
interestCoverageTTM	8.05	1.000	8.13	8.13	[3 - 30]
operatingCashFlowPerShareTTM	4.87	2.00	8.38	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.71	2.00	8.15	10.00	[0 - 20]
debtEquityRatioTTM	0.485	-1.500	8.06	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.655	1.000	2.42	2.42	[0.2 - 0.8]
operatingProfitMarginTTM	0.175	1.000	8.50	8.50	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.258	1.000	9.68	9.68	[0.2 - 2]
assetTurnoverTTM	0.356	0.800	-0.961	-0.769	[0.5 - 2]
Total Score				9.19

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	25.60	1.000	7.51	0	[1 - 100]
returnOnEquityTTM	0.0816	2.50	-0.131	-0.307	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.71	2.00	8.76	10.00	[0 - 30]
dividendYielPercentageTTM	3.41	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.87	2.00	8.38	10.00	[0 - 30]
payoutRatioTTM	0.871	1.500	1.293	-1.293	[0 - 1]
pegRatioTTM	-1.044	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.200	1.000	7.50	0	[0.1 - 0.5]
Total Score				3.66

Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.